[PERSON]
Pascal Soriot
Featured in 5 tracked stories · first seen
Situations
AstraZeneca regulatory and portfolio developments
3 clusters · 5 sources · last updated
Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments
AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE
Also covered in
-
AstraZeneca beats Q2 forecasts as oncology sales rise, but Ultomiris misses late‑stage trial goal
[BUSINESS] · 30 sources ·